Syndicate content
Pharmaceutical industry

Globesity: Weighing up the options
13/05/2012 - HEALTH

Globesity: Weighing up the options

The French might be renowned for their slim figures, but in reality, France is catching up with the United States. One in two adults is overweight and the situation in France now resembles that of the US twenty years ago. We weigh up efforts to beat globesity – a new term that describes the growing global health problem.
Mediator: the scandal that's rocked the drug world
07/09/2011 - FRANCE

Mediator: the scandal that's rocked the drug world

The Mediator affair continues to haunt France's second largest pharmaceutical, Servier. New revelations allege that the company falsified documents to get the pill marketed as a diabetic drug although they were aware of its appetite-suppressant qualities. Mediator was pulled off the shelves in 2009 by French health authorities amid concerns that it had fatal side-effects. We take a closer look at the latest developments.
Judging Jacques Chirac: is there any point?
06/09/2011 - IN THE FRENCH PAPERS

Judging Jacques Chirac: is there any point?

In Tuesday's French papers, we ask whether it's even worth judging Jacques Chirac on 20-year-old corruption charges, take a look at fresh fears for the eurozone, and discover documents showing a French pharmaceutical company lied about the controversial drug Mediator - for 40 years.
Greece for sale
16/06/2011 - IN THE PAPERS NATIONAL

Greece for sale

In Thursday's French papers - the Greek contagion could spread to French banks, debate hots up on the legalisation of cannabis, and the US State Department has some recommendations for travellers to France.
(1) comment
Pharma-scandals: two drugs, two different stories
21/05/2011 - BEYOND BUSINESS

Pharma-scandals: two drugs, two different stories

Are all pharmaceuticals companies equal before French regulators? In this edition of Beyond Business we take a look at two different case studies, and two different drugs. Both were given to diabetics, and both were linked to increased rates of heart disease. However, only one of the drugs attracted widespread scrutiny and public attention.
Mediator - France's biggest medical scandal? (part 2)
20/01/2011 - POLITICS

Mediator - France's biggest medical scandal? (part 2)

Marc Perelman interviews Gregory Caret, Director of Studies Department at the "UFC - Que Choisir" association; Jean Jacques Zambrowski, Hospital Physician and Professor of Health Economics at Paris Descartes University; and Alain Marié, Medical Editor at "Decision Santé" Magazine.
Mediator - France's biggest medical scandal?
20/01/2011 - POLITICS

Mediator - France's biggest medical scandal?

Marc Perelman interviews Gregory Caret, Director of Studies Department at the "UFC - Que Choisir" association; Jean Jacques Zambrowski, Hospital Physician and Professor of Health Economics at Paris Descartes University; and Alain Marié, Medical Editor at "Decision Santé" Magazine.
(1) comment
Mediator: the case goes to court
11/01/2011 - FRANCE

Mediator: the case goes to court

Patients who were prescribed the controversial Mediator drug have lodged a complaint in a French court. The medication was given by doctors to people with diabetics, as well as being used as an appetite suppressant, from 1976 until it was banned in 2009. Now it's been linked to the deaths of some former users; France's healthcare agency says the death rate could be as high as 2,000 people.
Chemical companies repsonsible for cancer increase?
06/12/2010 - CULTURE

Chemical companies repsonsible for cancer increase?

Today on culture, film director Emmanuelle Schick Garcia talks about her latest documentary called “The Idiot Cycle”. She argues that chemical companies are responsible for the rapid increase of cancer cases in the last decades. Doctors and experts she interviewed highlight that there’s a crucial lack of independent studies on the matter. Many have compared Schick Garcia to Michael Moore, in her style and approach to stories. You’re about to see why...
(1) comment
Genzyme rejects Sanofi bid
02/09/2010 - THE WEEK IN BUSINESS

Genzyme rejects Sanofi bid

Stéphane Marchand tells us why French pharmaceutical group Sanofi-Aventis is so determined to take over American company Genzyme.
Close